Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bora Pharmaceuticals
Taipei, Taiwan
- Ownership
- Private
- Employees
- ~2000
- Development stage
- Other
01
Overview
Bora Pharmaceuticals is a leading global CDMO with clinical-to-commercial capabilities spanning small molecules, biologics, probiotics, and nutraceuticals, serving over 100 markets worldwide and recently expanding into the rare disease market with FDA-approved and patented products[1][5][6][9].
- Therapeutic areas
- CardiovascularEndocrinologyNeurologyRare DiseasesOther
- Modalities
- Small moleculeBiologicMonoclonal antibodyBiosimilarProbioticDietary supplementSterile injectable
- Industry
- Contract Manufacturing Organization
02
Partnerships
InvaGen Pharmaceuticals (a Cipla Group company)Sunway BiotechTanvex BioPharma
Beyond the preview
Go deeper on Bora Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bora Pharmaceuticals.